In non-small cell lung cancer, miR-106b-25 cluster targets b-TRCP2 and enhances cell migration and invasion [60], while in acute myeloid leukemia (AML), it targets CASP7, influencing cell proliferation, chemoresistance, and apoptosis [61]. This evidence concerns the gene FBXW11 and acute myeloid leukemia.